Article

Ushering in the New Toxicology: Toxicogenomics and the Public Interest

Environmental Defense, Washington, DC 20009, USA.
Environmental Health Perspectives (Impact Factor: 7.98). 08/2005; 113(7):818-22. DOI: 10.1289/ehp.7732
Source: PubMed

ABSTRACT

New scientific tools spawned by the genomics revolution promise to improve our ability to identify causative factors in human diseases. But as these new tools elucidate the complex interactions between chemical toxins and biologic systems, the strain on traditional ways of understanding toxic effects grows. Despite major advances in the science and technology of these new toxicogenomics tools, scientific and political complexities threaten to delay the use of toxicogenomics to further the public interest or--worse--to advance its use initially to weaken the regulation and safety of widely used chemicals. To gain further insight into the scientific and political landscape of the new toxicology, we interviewed 27 experts from a variety of disciplines and sectors. Interviewees expressed widespread agreement that the new toxicology promises a significant increase in the amount of information available on toxic effects of chemicals. But the interviews show that the promise of the new toxicology will be realized only if technical and political obstacles can be overcome. Although scientific rigor is necessary for the new toxicology to move forward, the scientific and public-interest communities must ensure that inappropriate definitions of rigor, as well as proprietary interests, do not create unnecessary barriers to more effective public health protection.

Download full-text

Full-text

Available from: John Balbus, Nov 16, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Since its inception, there have been high expectations for the science of toxicogenomics to decrease the uncertainties associated with the risk assessment process by providing valuable insights into toxic mechanisms of action. However, the application of these data into risk assessment practices is still in the early stages of development, and proof of principle experiments have yet to emerge. The following discusses some potential applications as well as impediments that warrant a concerted investigation from all stakeholders in order to facilitate the acceptance and subsequent incorporation of toxicogenomics into regulatory decision making.
    Preview · Article · Mar 2006 · Toxicological Sciences
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This is the 56th report of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). The main goal of ECVAM, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which have scientific relevance and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures that would enable it to become well informed about the state-of-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which focused groups of invited experts would review the current status of non animal-based tests and their potential uses, and make recommendations about the best ways forward (1). The ECVAM workshop on repeated dose toxicity in vitro was held on 15-17 September 2004, at ECVAM in Ispra, Italy. The workshop was chaired by Walter Pfaller and Pilar Prieto, and was attended by pharmacologists and toxicologists from academia, industry and government, from different research backgrounds and with different ways of thinking. The main goal was to discuss and evaluate alternative approaches to In vivo repeated dose toxicity testing.
    Full-text · Article · Jul 2006 · Alternatives to laboratory animals: ATLA
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent years have witnessed an explosion of different genomic approaches which, through a combination of advanced biological, instrumental and bioinformatic techniques, can yield a previously unparalleled amount of data concerning the molecular and biochemical status of organisms. Fueled partially by large, well-publicized efforts such as the human genome project, genomic research has become a rapidly growing topical area in multiple biological disciplines. Since 1999 when the term toxicogenomics was coined to describe the application of genomics to toxicology, a citation analysis reveals a rapid increase in publications dealing with the topic. The potential utility of toxicogenomics in toxicological research and regulatory activities has been the subject of scientific discussions and, as with any new technology, there is a wide range of opinion. The purpose of this feature article is to consider roles of toxicogenomics in the field of regulatory ecotoxicology, explore current limitations in the science and practice of genomics, and propose possible avenues to approach and resolve some of the major challenges. A significant amount of input to our analysis came from a workshop sponsored by the Society of Environmental Toxicology and Chemistry in Pellston, MI in September, 2005.
    Full-text · Article · Aug 2006 · Environmental Science and Technology
Show more